University of Nebraska Medical Center College of Medicine Dermatology

Topics

• Nonmelanoma Skin Cancer Studies 112
• Cutaneous Melanoma Detection and Management 66
• Lymphoma Diagnosis and Treatment 61
• Psoriasis: Treatment and Pathogenesis 40
• Cutaneous lymphoproliferative disorders research 32
• CAR-T cell therapy research 28
• Hidradenitis Suppurativa and Treatments 23
• Systemic Lupus Erythematosus Research 21
• Sarcoma Diagnosis and Treatment 20
• Cancer and Skin Lesions 19
• Dermatology and Skin Diseases 18
• Autoimmune Bullous Skin Diseases 17

Most cited

1. Lisocabtagene maraleucel versus standard of care with salvage chemotherapy followed by autologous stem cell transplantation as second-line treatment in patients with relapsed or refractory large B-cell lymphoma (TRANSFORM): results from an interim analysis of an open-label, randomised, phase 3 trial.

   Lancet (London, England) · 2022 · 698 citations · Matthew Lunning

2. Lisocabtagene maraleucel as second-line therapy for large B-cell lymphoma: primary analysis of the phase 3 TRANSFORM study.

   Blood · 2023 · 369 citations · Matthew Lunning

3. Dermatofibrosarcoma Protuberans, Version 1.2025, NCCN Clinical Practice Guidelines In Oncology.

   Journal of the National Comprehensive Cancer Network : JNCCN · 2025 · 80 citations · Dominick DiMaio

4. Two-year follow-up of lisocabtagene maraleucel in relapsed or refractory large B-cell lymphoma in TRANSCEND NHL 001.

   Blood · 2024 · 171 citations · Matthew Lunning

5. Tumour extracellular vesicles and particles induce liver metabolic dysfunction.

   Nature · 2023 · 239 citations · Dominick DiMaio

6. NCCN Guidelines® Insights: Melanoma: Cutaneous, Version 2.2021.

   Journal of the National Comprehensive Cancer Network : JNCCN · 2021 · 269 citations ·